The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000527.5(LDLR):c.1329G>T (p.Trp443Cys)

CA10585410

251793 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: b56be71f-abe1-4414-b266-91bc2874bbb0
Approved on: 2025-01-31
Published on: 2025-02-03

HGVS expressions

NM_000527.5:c.1329G>T
NM_000527.5(LDLR):c.1329G>T (p.Trp443Cys)
NC_000019.10:g.11113420G>T
CM000681.2:g.11113420G>T
NC_000019.9:g.11224096G>T
CM000681.1:g.11224096G>T
NC_000019.8:g.11085096G>T
NG_009060.1:g.29040G>T
ENST00000252444.10:c.1587G>T
ENST00000559340.2:c.1329G>T
ENST00000560467.2:c.1209G>T
ENST00000558518.6:c.1329G>T
ENST00000252444.9:c.1583G>T
ENST00000455727.6:c.825G>T
ENST00000535915.5:c.1206G>T
ENST00000545707.5:c.948G>T
ENST00000557933.5:c.1329G>T
ENST00000558013.5:c.1329G>T
ENST00000558518.5:c.1329G>T
ENST00000559340.1:c.50G>T
ENST00000560173.1:n.328G>T
ENST00000560467.1:c.809G>T
NM_000527.4:c.1329G>T
NM_001195798.1:c.1329G>T
NM_001195799.1:c.1206G>T
NM_001195800.1:c.825G>T
NM_001195803.1:c.948G>T
NM_001195798.2:c.1329G>T
NM_001195799.2:c.1206G>T
NM_001195800.2:c.825G>T
NM_001195803.2:c.948G>T
More

Likely Pathogenic

Met criteria codes 5
PS1 PP4 PP3 PM2 PS4_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1329G>T (p.Trp443Cys) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PS1, PM2, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 31 January 2025. The supporting evidence is as follows: PM2: PopMax MAF = 0.0000006841 (0.00006841%) in European (non-Finnish) exomes (gnomAD v4.1.0). PP3: REVEL = 0.961. PS1: 1 missense variant that leads to the same amino acid change - NM_000527.5(LDLR):c.1329G>C (p.Trp443Cys) variant (ClinVar ID 251792), classified as Pathogenic by these guidelines. PS4_Supporting, PP4: Variant meets PM2 and is identified in at least 3 unrelated index cases who fulfill DLCN score >=6 (2 cases from Robarts Research Institute, Canada; 1 case from PMID 11810272- Fouchier et al., 2001, The Netherlands).
Met criteria codes
PS1
1 more missense variant that leads to the same amino acid change: - NM_000527.5(LDLR):c.1329G>C (p.Trp443Cys) variant (ClinVar ID 251792) - classified as Pathogenic by these guidelines
PP4
Variant meets PM2 and is identified in at least 1 index case who fulfills DLCN>=6 criteria for FH (Robarts Research Institute) after alternative causes of high cholesterol were excluded.
PP3
REVEL = 0.961
PM2
PopMax MAF = 0.0000006841 (0.00006841%) in European (non-Finnish) exomes (gnomAD v4.1.0).
PS4_Supporting
Variant meets PM2 and is identified in at least 3 unrelated index cases who fulfill DLCN>=6 criteria for FH: (1): Robarts Research Institute- 2 FH patients with DLCN >=6 carry variant (2): PMID: 11810272- 1 FH patients with DLCN >=6 carry variant
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.